{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:06:11Z","timestamp":1792073171960,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbc.2026.112201","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:09:55Z","timestamp":1777097395000},"page":"112201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profiling of fatty acids and lipids in animal and human tissues yields new leads for disease progression biomarkers of X-linked adrenoleukodystrophy"],"prefix":"10.1016","volume":"302","author":[{"given":"Alla","family":"Kloss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Brezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Kayatekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7284-4259","authenticated-orcid":false,"given":"Tatiana","family":"Gladysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.112201_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) Transporter Family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.jbc.2026.112201_bib2","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1073\/pnas.1005572107","article-title":"ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis","volume":"107","author":"Ohno","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.112201_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.112201_bib4","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and Hepatocarcinomas","volume":"284","author":"Silke Imgrund","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.112201_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6786245","article-title":"ABC transporter subfamily D: distinct differences in behavior between ABCD1-3 and ABCD4 in subcellular localization, function, and human disease","volume":"2016","author":"Kawaguchi","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jbc.2026.112201_bib6","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","article-title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy","volume":"13","author":"Pujol","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.112201_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1750-3639.2010.00393.x","article-title":"Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy","volume":"20","author":"Berger","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jbc.2026.112201_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.jbc.2026.112201_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.112201_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0033-1364179","article-title":"Hematopoietic stem cell transplantation in the leukodystrophies: a systematic review of the literature","volume":"45","author":"Musolino","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jbc.2026.112201_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2000-9236","article-title":"X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients","volume":"31","author":"Moser","year":"2000","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jbc.2026.112201_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11940-019-0605-y","article-title":"The landscape of hematopoietic stem cell transplant and gene therapy for X-Linked adrenoleukodystrophy","volume":"21","author":"Mallack","year":"2019","journal-title":"Curr. Treat Options Neurol."},{"key":"10.1016\/j.jbc.2026.112201_bib13","doi-asserted-by":"crossref","first-page":"e1698","DOI":"10.1212\/WNL.0000000000007294","article-title":"MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy","volume":"92","author":"Liberato","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2026.112201_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","article-title":"Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings","volume":"89","author":"Hubbard","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jbc.2026.112201_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jbc.2026.112201_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2016.68","article-title":"Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation","volume":"19","author":"Kemper","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.jbc.2026.112201_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fcell.2020.00520","article-title":"Multi-Omic approach to identify phenotypic modifiers underlying cerebral demyelination in X-Linked Adrenoleukodystrophy","volume":"8","author":"Richmond","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.112201_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s43856-024-00605-9","article-title":"Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy","volume":"4","author":"Jaspers","year":"2024","journal-title":"Commun. Med. (Lond)"},{"key":"10.1016\/j.jbc.2026.112201_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1471-4159.1993.tb03567.x","article-title":"Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients","volume":"61","author":"Wilson","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbc.2026.112201_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122906","article-title":"Prediction of subcutaneous drug absorption - characterization of subcutaneous interstitial fluids as a basis for developing biorelevant in vitro models","volume":"638","author":"Torres-Ter\u00e1n","year":"2023","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.jbc.2026.112201_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113248","article-title":"Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy","volume":"28","author":"Huang","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2026.112201_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of Oligodendrocyte and Myelin in the Mammalian central nervous System","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jbc.2026.112201_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225307","article-title":"Sample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity","volume":"25","author":"Liakh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2026.112201_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s004010050937","article-title":"Antisulfatide polyneuropathy: Antibody-mediated complement attack on peripheral myelin","volume":"96","author":"Ferrari","year":"1998","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.jbc.2026.112201_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12035-008-8022-3","article-title":"The role and metabolism of sulfatide in the nervous System","volume":"37","author":"Eckhardt","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2026.112201_bib26","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/bi952824c","article-title":"Study by infrared spectroscopy of the interdigitation of C26:0 cerebroside sulfate into phosphatidylcholine bilayers","volume":"35","author":"Nabet","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2026.112201_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","article-title":"Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment","volume":"281","author":"Campagnolo","year":"2015","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.jbc.2026.112201_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1194\/jlr.M002329","article-title":"Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy","volume":"51","author":"Khan","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2026.112201_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104781","article-title":"Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy","volume":"96","author":"Weinhofer","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2026.112201_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4062\/biomolther.2014.017","article-title":"Metabolism of very long-chain Fatty acids: genes and pathophysiology","volume":"22","author":"Sassa","year":"2014","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.jbc.2026.112201_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","article-title":"Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy","volume":"84","author":"Kemp","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jbc.2026.112201_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2003.08.013","article-title":"Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies","volume":"14","author":"Paintlia","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2026.112201_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040812","article-title":"Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism","volume":"9","author":"Poitelon","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.112201_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041503","article-title":"Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism","volume":"7","author":"Jumpertz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.112201_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jb\/mvs105","article-title":"Very long-chain fatty acids: elongation, physiology and related disorders","volume":"152","author":"Kihara","year":"2012","journal-title":"J. Biochem."},{"key":"10.1016\/j.jbc.2026.112201_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00010","article-title":"Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease","volume":"11","author":"Tracey","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jbc.2026.112201_bib37","first-page":"216","article-title":"The essentiality of arachidonic acid in infant","volume":"8","author":"Hadley","year":"2016","journal-title":"Develop. Nutri."},{"key":"10.1016\/j.jbc.2026.112201_bib38","article-title":"Production of branched-chain very-long-chain fatty acids by fatty acid elongases and their tissue distribution in mammals","volume":"1866","author":"Tanno","year":"2021","journal-title":"Biochim. Biophys. Acta (Bba) - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jbc.2026.112201_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3945\/an.115.011387","article-title":"Pentadecanoic and heptadecanoic acids: multifaceted odd-chain fatty acids","volume":"7","author":"Pfeuffer","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.jbc.2026.112201_bib40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3390\/molecules20022425","article-title":"A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease","volume":"20","author":"Jenkins","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2026.112201_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-2275(20)39331-7","article-title":"Branched-chain and odd-numbered fatty acids and aldehydes in the nervous system of a patient with deranged vitamin B12 metabolism","volume":"14","author":"Kishimoto","year":"1973","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2026.112201_bib42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.112201_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tcb.2011.06.004","article-title":"Central nervous system myelin: structure, synthesis and assembly","volume":"21","author":"Aggarwal","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jbc.2026.112201_bib44","first-page":"1099","article-title":"Stability of the Myelin","volume":"147","author":"O'Brien","year":"1965","journal-title":"Membr. Sci."},{"key":"10.1016\/j.jbc.2026.112201_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.12997\/jla.2020.9.3.380","article-title":"Ceramide\/Sphingomyelin rheostat regulated by Sphingomyelin synthases and chronic diseases in murine models","volume":"9","author":"Taniguchi","year":"2020","journal-title":"J. Lipid Atheroscler."},{"key":"10.1016\/j.jbc.2026.112201_bib46","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/glycob\/cwab046","article-title":"Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease","volume":"31","author":"Reza","year":"2021","journal-title":"Glycobiology"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826010732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826010732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:32:09Z","timestamp":1787643129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826010732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0021925826010732"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.112201","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling of fatty acids and lipids in animal and human tissues yields new leads for disease progression biomarkers of X-linked adrenoleukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.112201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"112201"}}